Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
-
Award Number: R01CA266611
-
ORGANIZATION: NATIONAL CANCER INSTITUTE
-
OPDIV: NIH
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
-
PERIOD OF PERFORMANCE START DATE: 09/09/2022
-
PERIOD OF PERFORMANCE END DATE: 08/31/2028